BREAKINGتازہ ترینताज़ा खबर
Ecuador Fishermen Sue Trump Over US Boat StrikesEcuador Fishermen Sue Trump Over US Boat StrikesEcuador Fishermen Sue Trump Over US Boat StrikesIsrael Divided Over Possible New Iran StrikeIsrael Divided Over Possible New Iran StrikeIsrael Divided Over Possible New Iran StrikeRandy Travis Given 1% Chance Before ComebackRandy Travis Given 1% Chance Before ComebackRandy Travis Given 1% Chance Before ComebackFitness Coach in ICU With Meningitis After Bali HeadacheFitness Coach in ICU With Meningitis After Bali HeadacheFitness Coach in ICU With Meningitis After Bali Headache800,000 Young Pakistanis Chose Exit Over Protest800,000 Young Pakistanis Chose Exit Over Protest800,000 Young Pakistanis Chose Exit Over ProtestTrump May Hold Off Iran Attacks, Sources SayTrump May Hold Off Iran Attacks, Sources SayTrump May Hold Off Iran Attacks, Sources Say8 College Football Games Moved After Ground Stop8 College Football Games Moved After Ground Stop8 College Football Games Moved After Ground Stop6,600 US Flights Cancelled in Nationwide Ground Stop6,600 US Flights Cancelled in Nationwide Ground Stop6,600 US Flights Cancelled in Nationwide Ground StopFederalist Society Ready to Move On From TrumpFederalist Society Ready to Move On From TrumpFederalist Society Ready to Move On From TrumpCanberra Targets 30% More ASEAN Students by 2030Canberra Targets 30% More ASEAN Students by 2030Canberra Targets 30% More ASEAN Students by 2030El-Sayed: Stop Funding Foreign Armies With US TaxesEl-Sayed: Stop Funding Foreign Armies With US TaxesEl-Sayed: Stop Funding Foreign Armies With US TaxesCalifornia Democrats Probe Trump, Hold Off ImpeachmentCalifornia Democrats Probe Trump, Hold Off ImpeachmentCalifornia Democrats Probe Trump, Hold Off ImpeachmentWindows 11's New Run Box Arrives for All in DecemberWindows 11's New Run Box Arrives for All in DecemberWindows 11's New Run Box Arrives for All in DecemberRogan: Nunes Has Huge Striking Edge Over HarrisonRogan: Nunes Has Huge Striking Edge Over HarrisonRogan: Nunes Has Huge Striking Edge Over HarrisonStatins After 70: Stopping Them Raises Heart RiskStatins After 70: Stopping Them Raises Heart RiskStatins After 70: Stopping Them Raises Heart RiskNew Congress May Doubt Trump's Tough Cuba PolicyNew Congress May Doubt Trump's Tough Cuba PolicyNew Congress May Doubt Trump's Tough Cuba PolicyLHC Forms Larger Bench on PTI Symbol PleaLHC Forms Larger Bench on PTI Symbol PleaLHC Forms Larger Bench on PTI Symbol PleaNearly $20M Found in Hungary Corruption ProbeNearly $20M Found in Hungary Corruption ProbeNearly $20M Found in Hungary Corruption ProbeCybertruck Fans in Mourning, Demand Musk AnswersCybertruck Fans in Mourning, Demand Musk AnswersCybertruck Fans in Mourning, Demand Musk AnswersColorado Stuns No. 14 Houston 42-32 in UpsetColorado Stuns No. 14 Houston 42-32 in UpsetColorado Stuns No. 14 Houston 42-32 in UpsetEcuador Fishermen Sue Trump Over US Boat StrikesEcuador Fishermen Sue Trump Over US Boat StrikesEcuador Fishermen Sue Trump Over US Boat StrikesIsrael Divided Over Possible New Iran StrikeIsrael Divided Over Possible New Iran StrikeIsrael Divided Over Possible New Iran StrikeRandy Travis Given 1% Chance Before ComebackRandy Travis Given 1% Chance Before ComebackRandy Travis Given 1% Chance Before ComebackFitness Coach in ICU With Meningitis After Bali HeadacheFitness Coach in ICU With Meningitis After Bali HeadacheFitness Coach in ICU With Meningitis After Bali Headache800,000 Young Pakistanis Chose Exit Over Protest800,000 Young Pakistanis Chose Exit Over Protest800,000 Young Pakistanis Chose Exit Over ProtestTrump May Hold Off Iran Attacks, Sources SayTrump May Hold Off Iran Attacks, Sources SayTrump May Hold Off Iran Attacks, Sources Say8 College Football Games Moved After Ground Stop8 College Football Games Moved After Ground Stop8 College Football Games Moved After Ground Stop6,600 US Flights Cancelled in Nationwide Ground Stop6,600 US Flights Cancelled in Nationwide Ground Stop6,600 US Flights Cancelled in Nationwide Ground StopFederalist Society Ready to Move On From TrumpFederalist Society Ready to Move On From TrumpFederalist Society Ready to Move On From TrumpCanberra Targets 30% More ASEAN Students by 2030Canberra Targets 30% More ASEAN Students by 2030Canberra Targets 30% More ASEAN Students by 2030El-Sayed: Stop Funding Foreign Armies With US TaxesEl-Sayed: Stop Funding Foreign Armies With US TaxesEl-Sayed: Stop Funding Foreign Armies With US TaxesCalifornia Democrats Probe Trump, Hold Off ImpeachmentCalifornia Democrats Probe Trump, Hold Off ImpeachmentCalifornia Democrats Probe Trump, Hold Off ImpeachmentWindows 11's New Run Box Arrives for All in DecemberWindows 11's New Run Box Arrives for All in DecemberWindows 11's New Run Box Arrives for All in DecemberRogan: Nunes Has Huge Striking Edge Over HarrisonRogan: Nunes Has Huge Striking Edge Over HarrisonRogan: Nunes Has Huge Striking Edge Over HarrisonStatins After 70: Stopping Them Raises Heart RiskStatins After 70: Stopping Them Raises Heart RiskStatins After 70: Stopping Them Raises Heart RiskNew Congress May Doubt Trump's Tough Cuba PolicyNew Congress May Doubt Trump's Tough Cuba PolicyNew Congress May Doubt Trump's Tough Cuba PolicyLHC Forms Larger Bench on PTI Symbol PleaLHC Forms Larger Bench on PTI Symbol PleaLHC Forms Larger Bench on PTI Symbol PleaNearly $20M Found in Hungary Corruption ProbeNearly $20M Found in Hungary Corruption ProbeNearly $20M Found in Hungary Corruption ProbeCybertruck Fans in Mourning, Demand Musk AnswersCybertruck Fans in Mourning, Demand Musk AnswersCybertruck Fans in Mourning, Demand Musk AnswersColorado Stuns No. 14 Houston 42-32 in UpsetColorado Stuns No. 14 Houston 42-32 in UpsetColorado Stuns No. 14 Houston 42-32 in Upset
Advertisement
Text size:
Business • 2026-11-14, 04:21 GMT • ~1 min read

Cellectis to Cut 70% of Staff in Gene Therapy Pivot

Cellectis to Cut 70% of Staff in Gene Therapy Pivot

Cellectis to Cut 70% of Staff in Gene Therapy Pivot

Key points

اہم نکات

मुख्य बातें

  • Paris-based biotech Cellectis will cut up to 70% of its workforce as it pivots from CAR-T cancer therapies to in vivo gene editing, the company disclosed in its third-quarter results on Friday.
  • The firm entered 2026 with 229 full-time staff across Paris, New York and Raleigh, North Carolina, and scrapped its two clinical-stage CAR-T programs in September.
  • It is now focused on two preclinical candidates, HEAL-101 and HEAL-201, with first trial data expected in 2027 and 2028.
  • Paris-based biotech Cellectis will cut up to 70% of its workforce as it pivots from CAR-T cancer therapies to in vivo gene editing, the company disclosed in its third-quarter results on Friday.
  • The firm entered 2026 with 229 full-time staff across Paris, New York and Raleigh, North Carolina, and scrapped its two clinical-stage CAR-T programs in September.
  • It is now focused on two preclinical candidates, HEAL-101 and HEAL-201, with first trial data expected in 2027 and 2028.
  • Paris-based biotech Cellectis will cut up to 70% of its workforce as it pivots from CAR-T cancer therapies to in vivo gene editing, the company disclosed in its third-quarter results on Friday.
  • The firm entered 2026 with 229 full-time staff across Paris, New York and Raleigh, North Carolina, and scrapped its two clinical-stage CAR-T programs in September.
  • It is now focused on two preclinical candidates, HEAL-101 and HEAL-201, with first trial data expected in 2027 and 2028.

Paris-based biotech Cellectis will cut up to 70% of its workforce as it pivots from CAR-T cancer therapies to in vivo gene editing, the company disclosed in its third-quarter results on Friday. The firm entered 2026 with 229 full-time staff across Paris, New York and Raleigh, North Carolina, and scrapped its two clinical-stage CAR-T programs in September. It is now focused on two preclinical candidates, HEAL-101 and HEAL-201, with first trial data expected in 2027 and 2028. The cuts, spread over 2026 and 2027, are meant to stretch its $149 million cash pile into the second half of 2028.

Paris-based biotech Cellectis will cut up to 70% of its workforce as it pivots from CAR-T cancer therapies to in vivo gene editing, the company disclosed in its third-quarter results on Friday. The firm entered 2026 with 229 full-time staff across Paris, New York and Raleigh, North Carolina, and scrapped its two clinical-stage CAR-T programs in September. It is now focused on two preclinical candidates, HEAL-101 and HEAL-201, with first trial data expected in 2027 and 2028. The cuts, spread over 2026 and 2027, are meant to stretch its $149 million cash pile into the second half of 2028.

Paris-based biotech Cellectis will cut up to 70% of its workforce as it pivots from CAR-T cancer therapies to in vivo gene editing, the company disclosed in its third-quarter results on Friday. The firm entered 2026 with 229 full-time staff across Paris, New York and Raleigh, North Carolina, and scrapped its two clinical-stage CAR-T programs in September. It is now focused on two preclinical candidates, HEAL-101 and HEAL-201, with first trial data expected in 2027 and 2028. The cuts, spread over 2026 and 2027, are meant to stretch its $149 million cash pile into the second half of 2028.

Most read

سب سے زیادہ پڑھی گئی

सबसे ज़्यादा पढ़ी गई

  1. Loading...
Advertisement